Expression of adhesion molecules on CD4+ and CD8+ T cells isolated from healthy controls and MS patients
Lymphocyte subpopulation . | Donor . | CD162/PSGL-1, % (MFI) . | CD11a, % (MFI) . | CD62L, % (MFI) . | CD49d, % (MFI) . |
|---|---|---|---|---|---|
| CD4 | Healthy | 91 ± 4 (138 ± 42) | 98 ± 1 (73 ± 10) | 66 ± 8 (255 ± 51) | 87 ± 8 (19 ± 5) |
| CD4 | MS | 99 ± 0.5 (308 ± 130) | 98 ± 0.5 (66 ± 35) | 61 ± 19 (305 ± 217) | 90 ± 10 (31 ± 24) |
| CD8 | Healthy | 96 ± 3 (235 ± 106) | 91 ± 4 (109 ± 26) | 49 ± 12 (154 ± 10) | 91 ± 17 (31 ± 7) |
| CD8 | MS | 98 ± 2 (433 ± 125) | 99 ± 0.5 (128 ± 75) | 34 ± 19 (145 ± 119) | 92 ± 18 (41 ± 31) |
Lymphocyte subpopulation . | Donor . | CD162/PSGL-1, % (MFI) . | CD11a, % (MFI) . | CD62L, % (MFI) . | CD49d, % (MFI) . |
|---|---|---|---|---|---|
| CD4 | Healthy | 91 ± 4 (138 ± 42) | 98 ± 1 (73 ± 10) | 66 ± 8 (255 ± 51) | 87 ± 8 (19 ± 5) |
| CD4 | MS | 99 ± 0.5 (308 ± 130) | 98 ± 0.5 (66 ± 35) | 61 ± 19 (305 ± 217) | 90 ± 10 (31 ± 24) |
| CD8 | Healthy | 96 ± 3 (235 ± 106) | 91 ± 4 (109 ± 26) | 49 ± 12 (154 ± 10) | 91 ± 17 (31 ± 7) |
| CD8 | MS | 98 ± 2 (433 ± 125) | 99 ± 0.5 (128 ± 75) | 34 ± 19 (145 ± 119) | 92 ± 18 (41 ± 31) |
Shown are the percentages and MFIs of marker-positive cells in the total population of 4 to 8 experiments.